Sabater E, López-Guillermo A, Rueda A, Salar A, Oyagüez I, Collar JM Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain Appl Health Econ Health Policy 2016;14(4):465-77 MÁS INFORMACIÓN
